25.09 FDA

alt 2013 , 2012 , Fitch Ratings.

2013 FDA 18 , 2012 22 . 2012 39 , 2004 .

FDA , . , . 2012 Food and Drug Administration Safety and Innovation Act, . 2012 2013 FDA 83 , 26 .

FDA , . .

, , , . , . 2014 FDA , sofosbuvir Gilead Sciences; Anoro Ellipta GlaxoSmithKline; () Opsumit Actelion; Adempas Bayer .

, . , sugammadex Merck FDA. Tresiba Novo Nordisk . Novo Nordisk .